These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 27889489)

  • 1. The drug candidate, ADX71441, is a novel, potent and selective positive allosteric modulator of the GABA
    Kalinichev M; Girard F; Haddouk H; Rouillier M; Riguet E; Royer-Urios I; Mutel V; Lütjens R; Poli S
    Neuropharmacology; 2017 Mar; 114():34-47. PubMed ID: 27889489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ADX71943 and ADX71441, novel positive allosteric modulators of the GABA
    Kalinichev M; Donovan-Rodriguez T; Girard F; Haddouk H; Royer-Urios I; Schneider M; Bate ST; Marker C; Pomonis JD; Poli S
    Eur J Pharmacol; 2017 Jan; 795():43-49. PubMed ID: 27916555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The GABA
    Augier E; Dulman RS; Damadzic R; Pilling A; Hamilton JP; Heilig M
    Neuropsychopharmacology; 2017 Aug; 42(9):1789-1799. PubMed ID: 28294133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analgesic effect of ADX71441, a positive allosteric modulator (PAM) of GABA
    Kannampalli P; Poli SM; Boléa C; Sengupta JN
    Neuropharmacology; 2017 Nov; 126():1-11. PubMed ID: 28823612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ADX71441, a novel, potent and selective positive allosteric modulator of the GABA(B) receptor, shows efficacy in rodent models of overactive bladder.
    Kalinichev M; Palea S; Haddouk H; Royer-Urios I; Guilloteau V; Lluel P; Schneider M; Saporito M; Poli S
    Br J Pharmacol; 2014 Feb; 171(4):995-1006. PubMed ID: 24224799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Behavioral characterization of the novel GABAB receptor-positive modulator GS39783 (N,N'-dicyclopentyl-2-methylsulfanyl-5-nitro-pyrimidine-4,6-diamine): anxiolytic-like activity without side effects associated with baclofen or benzodiazepines.
    Cryan JF; Kelly PH; Chaperon F; Gentsch C; Mombereau C; Lingenhoehl K; Froestl W; Bettler B; Kaupmann K; Spooren WP
    J Pharmacol Exp Ther; 2004 Sep; 310(3):952-63. PubMed ID: 15113848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction of excessive alcohol drinking by a novel GABAB receptor positive allosteric modulator ADX71441 in mice.
    Hwa LS; Kalinichev M; Haddouk H; Poli S; Miczek KA
    Psychopharmacology (Berl); 2014 Jan; 231(2):333-43. PubMed ID: 23975038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ADX71743, a potent and selective negative allosteric modulator of metabotropic glutamate receptor 7: in vitro and in vivo characterization.
    Kalinichev M; Rouillier M; Girard F; Royer-Urios I; Bournique B; Finn T; Charvin D; Campo B; Le Poul E; Mutel V; Poli S; Neale SA; Salt TE; Lütjens R
    J Pharmacol Exp Ther; 2013 Mar; 344(3):624-36. PubMed ID: 23257312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of peripheral versus central effects of GABA(B) receptor activation using a novel, positive allosteric modulator of the GABA(B) receptor ADX71943, a pharmacological tool compound with a fully peripheral activity profile.
    Kalinichev M; Donovan-Rodriguez T; Girard F; Riguet E; Rouillier M; Bournique B; Haddouk H; Mutel V; Poli S
    Br J Pharmacol; 2014 Nov; 171(21):4941-54. PubMed ID: 24923436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the anxiolytic-like profile of the GABAB receptor positive modulator CGP7930 in rodents.
    Jacobson LH; Cryan JF
    Neuropharmacology; 2008 Apr; 54(5):854-62. PubMed ID: 18328507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticonvulsant effects of structurally diverse GABA(B) positive allosteric modulators in the DBA/2J audiogenic seizure test: Comparison to baclofen and utility as a pharmacodynamic screening model.
    Brown JW; Moeller A; Schmidt M; Turner SC; Nimmrich V; Ma J; Rueter LE; van der Kam E; Zhang M
    Neuropharmacology; 2016 Feb; 101():358-69. PubMed ID: 26471422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the novel positive allosteric modulator of the metabotropic glutamate receptor 4 ADX88178 in rodent models of neuropsychiatric disorders.
    Kalinichev M; Le Poul E; Boléa C; Girard F; Campo B; Fonsi M; Royer-Urios I; Browne SE; Uslaner JM; Davis MJ; Raber J; Duvoisin R; Bate ST; Reynolds IJ; Poli S; Celanire S
    J Pharmacol Exp Ther; 2014 Sep; 350(3):495-505. PubMed ID: 24947466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of (R,S)-5,7-di-tert-butyl-3-hydroxy-3-trifluoromethyl-3H-benzofuran-2-one as a positive allosteric modulator of GABAB receptors.
    Malherbe P; Masciadri R; Norcross RD; Knoflach F; Kratzeisen C; Zenner MT; Kolb Y; Marcuz A; Huwyler J; Nakagawa T; Porter RH; Thomas AW; Wettstein JG; Sleight AJ; Spooren W; Prinssen EP
    Br J Pharmacol; 2008 Jun; 154(4):797-811. PubMed ID: 18536733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The GABA(B) receptor positive modulator BHF177 attenuated anxiety, but not conditioned fear, in rats.
    Li X; Kaczanowska K; Finn MG; Markou A; Risbrough VB
    Neuropharmacology; 2015 Oct; 97():357-64. PubMed ID: 26002628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the effects of the GABAB receptor positive modulator BHF177 and the GABAB receptor agonist baclofen on anxiety-like behavior, learning, and memory in mice.
    Li X; Risbrough VB; Cates-Gatto C; Kaczanowska K; Finn MG; Roberts AJ; Markou A
    Neuropharmacology; 2013 Jul; 70():156-67. PubMed ID: 23376712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent Advances in the Potential of Positive Allosteric Modulators of the GABAB Receptor to Treat Alcohol Use Disorder.
    Augier E
    Alcohol Alcohol; 2021 Feb; 56(2):139-148. PubMed ID: 33561865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel GABA
    Murai N; Kondo Y; Akuzawa S; Mihara T; Shiraishi N; Kakimoto S; Matsumoto M
    Eur J Pharmacol; 2019 Dec; 865():172750. PubMed ID: 31647906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Positive allosteric modulation of A
    Vincenzi F; Ravani A; Pasquini S; Merighi S; Gessi S; Romagnoli R; Baraldi PG; Borea PA; Varani K
    Neuropharmacology; 2016 Dec; 111():283-292. PubMed ID: 27639989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro and in vivo characterization of the novel GABAB receptor positive allosteric modulator, 2-{1-[2-(4-chlorophenyl)-5-methylpyrazolo[1,5-a]pyrimidin-7-yl]-2-piperidinyl}ethanol (CMPPE).
    Perdona' E; Costantini VJ; Tessari M; Martinelli P; Carignani C; Valerio E; Mok MH; Zonzini L; Visentini F; Gianotti M; Gordon L; Rocheville M; Corsi M; Capelli AM
    Neuropharmacology; 2011; 61(5-6):957-66. PubMed ID: 21756923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and in vivo pharmacological characterization of SSD114, a novel GABAB positive allosteric modulator.
    Porcu A; Lobina C; Giunta D; Solinas M; Mugnaini C; Castelli MP
    Eur J Pharmacol; 2016 Nov; 791():115-123. PubMed ID: 27578262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.